For latest News and updates
Posted by Physicians Weekly | Jan 8, 2020
Significantly more patients treated with Ubrelvy versus placebo achieved pain freedom two hours post-treatment TUESDAY, Dec. 24, 2019 (HealthDay News) — Ubrelvy (ubrogepant) tablets have been approved for acute treatment...
Read MorePosted by Physicians Weekly | Dec 27, 2019
The longer patients continue with buprenorphine treatment, the lower their risk of adverse outcomes. THURSDAY, Dec. 26, 2019 (HealthDay News) — Buprenorphine treatment may be needed for several years after an opioid...
Read More